Evidence map›Paper›PMID 33924783›Full record

ArticleBiosensors2021

Bioengineering of Genetically Encoded Gene Promoter Repressed by the Flavonoid Apigenin for Constructing Intracellular Sensor for Molecular Events.

Nicole M Desmet, Kalyani Dhusia, Wenjie Qi, Andrea I Doseff, Sudin Bhattacharya, Assaf A Gilad

Open access · goldAbstract read
In one paragraph

Article in Biosensors, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nicole M DesmetDepartment of Biomedical Engineering, Michigan State University, East Lansing, MI 48824, USA.
Kalyani DhusiaDepartment of Biomedical Engineering, Michigan State University, East Lansing, MI 48824, USA.
Wenjie QiDepartment of Biomedical Engineering, Michigan State University, East Lansing, MI 48824, USA.
Andrea I DoseffDepartment of Physiology, Michigan State University, East Lansing, MI 48824, USA.ORCID 0000-0002-4478-9854
Sudin BhattacharyaDepartment of Biomedical Engineering, Michigan State University, East Lansing, MI 48824, USA.ORCID 0000-0002-2360-1672
Assaf A GiladDepartment of Biomedical Engineering, Michigan State University, East Lansing, MI 48824, USA.
Michigan State University · US

Funding

Training/Dissemination-Resource for Molecular Imaging Agents in Precision MedicineP41EB024495 · NIBIB · UT SOUTHWESTERN MEDICAL CENTER · PI MARTIN G POMPER · 2017 to 2026
$11.8M
Bioengineering a novel electromagnetic perspective gene as a tool for wireless control of excitable cellsR01NS098231 · NINDS · MICHIGAN STATE UNIVERSITY · PI GILAD, ASSAF A, PELLED, GALIT · 2017 to 2021
$2.6M
Molecular Imaging for Detection of Synthetic Biology Circuits, Oscillators and Toggle Switches in Regenerative MedicineR01NS104306 · NINDS · MICHIGAN STATE UNIVERSITY · PI GILAD, ASSAF A · 2018 to 2021
$1.3M
NIBIB NIH HHS P41 EB024495NINDS NIH HHS R01 NS098231NINDS NIH HHS R01 NS104306
6 · The paper itself

Abstract

In recent years, Synthetic Biology has emerged as a new discipline where functions that were traditionally performed by electronic devices are replaced by "cellular devices"; genetically encoded circuits constructed of DNA that are built from biological parts (aka bio-parts). The cellular devices can be used for sensing and responding to natural and artificial signals. However, a major challenge in the field is that the crosstalk between many cellular signaling pathways use the same signaling endogenous molecules that can result in undesired activation. To overcome this problem, we utilized a specific promoter that can activate genes with a natural, non-toxic ligand at a highly-induced transcription level with low background or undesirable off-target expression. Here we used the orphan aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor that upon activation binds to specific AHR response elements (AHRE) of the Cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1) promoter. Flavonoids have been identified as AHR ligands. Data presented here show the successful creation of a synthetic gene "off" switch that can be monitored directly using an optical reporter gene. This is the first step towards bioengineering of a synthetic, nanoscale bio-part for constructing a sensor for molecular events.

Indexed as

Biosensing TechniquesApigeninBasic Helix-Loop-Helix ProteinsBioengineeringCytochrome P-450 CYP1A1FlavonoidsHumansLigandsProtein BindingReceptors, Aryl HydrocarbonSignal TransductionAHR protein, humanApigeninBasic Helix-Loop-Helix ProteinsCytochrome P-450 CYP1A1FlavonoidsLigandsReceptors, Aryl Hydrocarbonapigenincytochrome P450family 1flavonoidspolypeptide 1 (CYP1A1)subfamily A

Identifiers

PMID33924783
PMCPMC8147076
OpenAlexW3157405353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.